期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
代谢酶PCK2在非小细胞肺癌中的表达及功能 被引量:1
1
作者 陈德和 于观贞 +1 位作者 陈颖 李和根 《临床与实验病理学杂志》 CAS CSCD 北大核心 2019年第9期1065-1069,共5页
目的探讨PCK2在非小细胞肺癌组织中的表达及临床意义,干扰或过表达PCK2对肺癌细胞增殖和迁移能力的改变。方法构建含有75例非小细胞肺癌的组织芯片,采用免疫组化SP法检测PCK2在肺癌组织中的表达,分析PCK2过表达与临床病理特征的关系。构... 目的探讨PCK2在非小细胞肺癌组织中的表达及临床意义,干扰或过表达PCK2对肺癌细胞增殖和迁移能力的改变。方法构建含有75例非小细胞肺癌的组织芯片,采用免疫组化SP法检测PCK2在肺癌组织中的表达,分析PCK2过表达与临床病理特征的关系。构建PCK2-siRNA和过表达质粒,分别转染肺癌细胞,CCK8实验检测细胞增殖能力和Transwell小室实验检测细胞迁移能力。结果所有肺癌组织和癌旁非肿瘤组织中PCK2均呈不同程度表达,PCK2在肺癌组织中的过表达率为66.7%(50/75),PCK2过表达与淋巴结转移和TNM分期密切相关(P<0.05)。干扰PCK2表达后肺癌细胞增殖能力改变不显著,但迁移能力明显抑制,抑制率高达70.1%(P<0.000 1),过表达PCK2后肺癌细胞增殖能力无变化,但迁移能力上调2.5倍(P<0.000 1)。结论PCK2与肺癌转移和TNM分期相关,PCK2具有促进转移功能,PCK2有望成为预测肺癌转移的重要标志物,甚至可能成为肺癌治疗的潜在靶点。 展开更多
关键词 肺肿瘤 非小细胞肺癌 pck2 转移
暂未订购
PCK2蛋白序列特征、分子进化与突变分析
2
作者 薛振 左瑶 +4 位作者 马海东 王令 王珊珊 路宏朝 张涛 《石河子大学学报(自然科学版)》 CAS 北大核心 2022年第6期749-757,共9页
磷酸烯醇式丙酮酸羧激酶2(phosphoenolpyruvate carboxykinase 2,PCK2)是连接TCA循环、糖酵解和糖异生的枢纽分子,动态调节细胞内的合成代谢以提供足够的能量和代谢中间体。PCK2广泛参与糖代谢、脂代谢、衰老、糖尿病以及肿瘤细胞增殖... 磷酸烯醇式丙酮酸羧激酶2(phosphoenolpyruvate carboxykinase 2,PCK2)是连接TCA循环、糖酵解和糖异生的枢纽分子,动态调节细胞内的合成代谢以提供足够的能量和代谢中间体。PCK2广泛参与糖代谢、脂代谢、衰老、糖尿病以及肿瘤细胞增殖和凋亡等代谢和生物学进程。因此,深入挖掘其潜在功能将为疾病治疗靶点的探究提供帮助。本研究以PCK2蛋白为研究对象,对其分子进化特征,蛋白结构信息等方面进行全面分析。首先从蛋白质数据库UniportKB中获取32种代表性物种氨基酸序列,对其进行理化特性分析、多序列比对、Motif分析及系统进化树构建,结果显示,该蛋白包含629~646个氨基酸残基,不同物种PCK2蛋白具有高度保守性,且进化树结构基本符合物种亲缘进化规律。基于前期研究发现的PCK2突变位点,本研究采用重叠延伸PCR技术构建小鼠PCK2基因的突变载体pCD513B-MU-PCK2-C3657T。通过多个软件预测分析小鼠PCK2突变对其蛋白的影响,结果显示PCK2-MU蛋白的理化特性与结构特征均发生明显的改变。进一步在细胞水平分析PCK2突变导致HEK293T细胞增殖能力显著降低。研究结果和突变载体可为后续PCK2的研究和应用提供借鉴与支撑。 展开更多
关键词 pck2 突变载体 分子进化 细胞增殖
在线阅读 下载PDF
The LncRNA FEZF1-AS1 promotes tumor proliferation in colon cancer by regulating the mitochondrial protein PCK2 被引量:1
3
作者 HUAMIN WANG YANTING WU +5 位作者 ZHENLEI WANG YUHANG CHEN JINYU MO WEN GUAN YALI ZHANG HONGLIANG YAO 《Oncology Research》 SCIE 2021年第3期201-215,共15页
LncRNAs and metabolism represents two factors involved in cancer initiation and progression.However,the interaction between lncRNAs and metabolism remains to be fully explored.In this study,lncRNA FEZF1-AS1(FEZF1-AS1)... LncRNAs and metabolism represents two factors involved in cancer initiation and progression.However,the interaction between lncRNAs and metabolism remains to be fully explored.In this study,lncRNA FEZF1-AS1(FEZF1-AS1)was found upregulated in colon cancer after screening all the lncRNAs of colon cancer tissues deposited in TCGA,the result of which was further confirmed by RNAscope staining on a colon tissue chip.The results obtained using FEZF1-AS1 knockout colon cancer cells(SW480 KO and HCT-116 KO)constructed using CRISPR/Cas9 system confirmed the proliferation,invasion,and migration-promoting function of FEZF1-AS1 in vitro.Mechanistically,FEZF1-AS1 associated with the mitochondrial protein phosphoenolpyruvate carboxykinase(PCK2),which plays an essential role in regulating energy metabolism in the mitochondria.Knockdown of FEZF1-AS1 greatly decreased PCK2 protein levels,broke the homeostasis of energy metabolism in the mitochondria,and inhibited proliferation,invasion,and migration of SW480 and HCT-116 cells.PCK2 overexpression in FEZF1-AS1 knockout cells partially rescued the tumor inhibitory effect on colon cancer cells both in vitro and in vivo.Moreover,PCK2 overexpression specifically rescued the abnormal accumulation of Flavin mononucleotide(FMN)and succinate,both of which play an important role in oxidative phosphorylation(OXPHOS).Overall,these results indicate that FEZF1-AS1 is an oncogene through regulating energy metabolism of the cell.This research reveals a new mechanism for lncRNAs to regulate colon cancer and provides a potential target for colon cancer diagnosis and treatment. 展开更多
关键词 Long non-coding RNA(LncRNA) Colon cancer Phosphoenolpyruvate carboxykinase2(pck2) Tricarboxylic acid cycle(TCA) GLYCOLYSIS Oxidative phosphorylation(OXPHOS)
暂未订购
The PCK2-glycolysis axis assists three-dimensional-stiffness maintaining stem cell osteogenesis 被引量:3
4
作者 Zheng Li Muxin Yue +4 位作者 Xuenan Liu Yunsong Liu Longwei Lv Ping Zhang Yongsheng Zhou 《Bioactive Materials》 SCIE 2022年第12期492-506,共15页
Understanding mechanisms underlying the heterogeneity of multipotent stem cells offers invaluable insights into biogenesis and tissue development. Extracellular matrix (ECM) stiffness has been acknowledged as a crucia... Understanding mechanisms underlying the heterogeneity of multipotent stem cells offers invaluable insights into biogenesis and tissue development. Extracellular matrix (ECM) stiffness has been acknowledged as a crucial factor regulating stem cell fate. However, how cells sense stiffness cues and adapt their metabolism activity is still unknown. Here we report the novel role of mitochondrial phosphoenolpyruvate carboxykinase (PCK2) in enhancing osteogenesis in 3D ECM via glycolysis. We experimentally mimicked the physical characteristics of 3D trabeculae network of normal and osteoporotic bone with different microstructure and stiffness, observing that PCK2 promotes osteogenesis in 3D ECM with tunable stiffness in vitro and in vivo. Mechanistically, PCK2 enhances the rate-limiting metabolic enzyme pallet isoform phosphofructokinase (PFKP) in 3D ECM, and further activates AKT/extracellular signal-regulated kinase 1/2 (ERK1/2) cascades, which directly regulates osteogenic differentiation of MSCs. Collectively, our findings implicate an intricate crosstalk between cell mechanics and metabolism, and provide new perspectives for strategies of osteoporosis. 展开更多
关键词 OSTEOGENESIS Osteoporosis Extracellular matrix STIFFNESS pck2 Mesenchymal stem cells
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部